Summary of Key Points Core Viewpoint - The announcement details the share pledge situation of the company's major shareholders, highlighting the percentage of shares pledged and the implications for the company's operations and governance. Group 1: Shareholding and Pledge Details - As of the announcement date, Mr. Luo Weiguo holds 37,251,829 shares, accounting for 12.84% of the total share capital, while Mr. Shi Dongwei holds 32,338,800 shares, representing 11.15% of the total share capital [1] - After the pledge, Mr. Luo has pledged a total of 22,000,000 shares, which is 59.06% of his holdings and 7.58% of the total share capital; Mr. Shi has pledged 29,000,000 shares, which is 89.68% of his holdings and 9.99% of the total share capital [1] - Together, Mr. Luo and Mr. Shi hold 69,590,629 shares, making up 23.98% of the total share capital, and after the pledge, they have pledged a total of 51,000,000 shares, which is 73.29% of their holdings and 17.58% of the total share capital [1] Group 2: Legal and Financial Status - Due to a legal dispute, 14,375,524 shares held by Mr. Luo are frozen, and 3,181,856 shares held by Mr. Shi are also frozen due to a contractual dispute [2] - Both Mr. Luo and Mr. Shi have good credit status and possess the financial capability to repay, with repayment funds sourced from their own resources, indicating that the pledge risk is controllable [2] - There is currently no risk of forced liquidation or margin call, and if a warning occurs, they will take measures such as additional pledges or early repayments [2] Group 3: Impact on the Company - The share pledge will not affect the company's main business, financing credit, financing costs, or ongoing operational capabilities [2] - The pledge will not influence the shareholders' ability to appoint directors to the company, nor will it affect the relationship between shareholders and the company regarding property, business, assets, or personnel [2] - The stability of control, shareholding structure, and daily management of the company will remain unaffected by this pledge [2]
证券代码：603717 证券简称：天域生物 公告编号：2025-055